Long term results of diode laser cycloablation in complex glaucoma using the Zeiss Visulas II system

S. Ataullah; S. Biswas; P. H. Artes; E. O'Donoghue; A. E A Ridgway; A. F. Spencer

doi:10.1136/bjo.86.1.39

Long term results of diode laser cycloablation in complex glaucoma using the Zeiss Visulas II system

S. Ataullah, S. Biswas, P. H. Artes, E. O'Donoghue, A. E A Ridgway, A. F. Spencer

Research output: Contribution to journal › Article › peer-review

Abstract

Aim: To investigate the safety and efficacy of the Zeiss Visulas II diode laser system in the reduction of intraocular pressure (IOP) in patients with complex glaucoma. Methods: The authors analysed the medical records of patients who underwent trans-scleral diode laser cycloablation (TDC) at the Manchester Royal Eye Hospital during a 34 month period. 55 eyes of 53 patients with complex glaucoma were followed up for a period of 12-52 months (mean 23.1 months) after initial treatment with the Zeiss Visulas II diode laser system. Results: Mean pretreatment IOP was 35.8 mm Hg (range 22-64 mm Hg). At the last examination, mean IOP was 17.3 mm Hg (range 0-40 mm Hg). After treatment, 45 eyes (82%) had an IOP between 5 and 22 mm Hg; in 46 eyes (84%) the preoperative IOP had been reduced by 30% or more. The mean number of treatment sessions was 1.7 (range 1-6). At the last follow up appointment, the mean number of glaucoma medications was reduced from 2.1 to 1.6 (p

Original language	English
Pages (from-to)	39-42
Number of pages	3
Journal	British Journal Of Ophthalmology
Volume	86
Issue number	1
DOIs	https://doi.org/10.1136/bjo.86.1.39
Publication status	Published - 2002

Access to Document

10.1136/bjo.86.1.39

Cite this

@article{1f28f652149747dc880eddeeff927aef,

title = "Long term results of diode laser cycloablation in complex glaucoma using the Zeiss Visulas II system",

abstract = "Aim: To investigate the safety and efficacy of the Zeiss Visulas II diode laser system in the reduction of intraocular pressure (IOP) in patients with complex glaucoma. Methods: The authors analysed the medical records of patients who underwent trans-scleral diode laser cycloablation (TDC) at the Manchester Royal Eye Hospital during a 34 month period. 55 eyes of 53 patients with complex glaucoma were followed up for a period of 12-52 months (mean 23.1 months) after initial treatment with the Zeiss Visulas II diode laser system. Results: Mean pretreatment IOP was 35.8 mm Hg (range 22-64 mm Hg). At the last examination, mean IOP was 17.3 mm Hg (range 0-40 mm Hg). After treatment, 45 eyes (82%) had an IOP between 5 and 22 mm Hg; in 46 eyes (84%) the preoperative IOP had been reduced by 30% or more. The mean number of treatment sessions was 1.7 (range 1-6). At the last follow up appointment, the mean number of glaucoma medications was reduced from 2.1 to 1.6 (p",

author = "S. Ataullah and S. Biswas and Artes, {P. H.} and E. O'Donoghue and Ridgway, {A. E A} and Spencer, {A. F.}",

year = "2002",

doi = "10.1136/bjo.86.1.39",

language = "English",

volume = "86",

pages = "39--42",

journal = "British Journal Of Ophthalmology",

issn = "0007-1161",

publisher = "BMJ ",

number = "1",

}

TY - JOUR

T1 - Long term results of diode laser cycloablation in complex glaucoma using the Zeiss Visulas II system

AU - Ataullah, S.

AU - Biswas, S.

AU - Artes, P. H.

AU - O'Donoghue, E.

AU - Ridgway, A. E A

AU - Spencer, A. F.

PY - 2002

Y1 - 2002

N2 - Aim: To investigate the safety and efficacy of the Zeiss Visulas II diode laser system in the reduction of intraocular pressure (IOP) in patients with complex glaucoma. Methods: The authors analysed the medical records of patients who underwent trans-scleral diode laser cycloablation (TDC) at the Manchester Royal Eye Hospital during a 34 month period. 55 eyes of 53 patients with complex glaucoma were followed up for a period of 12-52 months (mean 23.1 months) after initial treatment with the Zeiss Visulas II diode laser system. Results: Mean pretreatment IOP was 35.8 mm Hg (range 22-64 mm Hg). At the last examination, mean IOP was 17.3 mm Hg (range 0-40 mm Hg). After treatment, 45 eyes (82%) had an IOP between 5 and 22 mm Hg; in 46 eyes (84%) the preoperative IOP had been reduced by 30% or more. The mean number of treatment sessions was 1.7 (range 1-6). At the last follow up appointment, the mean number of glaucoma medications was reduced from 2.1 to 1.6 (p

AB - Aim: To investigate the safety and efficacy of the Zeiss Visulas II diode laser system in the reduction of intraocular pressure (IOP) in patients with complex glaucoma. Methods: The authors analysed the medical records of patients who underwent trans-scleral diode laser cycloablation (TDC) at the Manchester Royal Eye Hospital during a 34 month period. 55 eyes of 53 patients with complex glaucoma were followed up for a period of 12-52 months (mean 23.1 months) after initial treatment with the Zeiss Visulas II diode laser system. Results: Mean pretreatment IOP was 35.8 mm Hg (range 22-64 mm Hg). At the last examination, mean IOP was 17.3 mm Hg (range 0-40 mm Hg). After treatment, 45 eyes (82%) had an IOP between 5 and 22 mm Hg; in 46 eyes (84%) the preoperative IOP had been reduced by 30% or more. The mean number of treatment sessions was 1.7 (range 1-6). At the last follow up appointment, the mean number of glaucoma medications was reduced from 2.1 to 1.6 (p

U2 - 10.1136/bjo.86.1.39

DO - 10.1136/bjo.86.1.39

M3 - Article

SN - 0007-1161

VL - 86

SP - 39

EP - 42

JO - British Journal Of Ophthalmology

JF - British Journal Of Ophthalmology

IS - 1

ER -

Long term results of diode laser cycloablation in complex glaucoma using the Zeiss Visulas II system

Abstract

Access to Document

Fingerprint

Cite this